Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?

Blood Cancer J. 2018 Jan 12;8(1):8. doi: 10.1038/s41408-017-0046-3.

Authors

Maura Nicolosi¹, Mythri Mudireddy¹, Naseema Gangat¹, Animesh Pardanani¹, Curtis A Hanson¹, Rhett P Ketterling¹, Ayalew Tefferi²

Affiliations

¹ Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
² Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu.

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Female
Humans
Karyotype*
Karyotyping*
Male
Metaphase*
Middle Aged
Primary Myelofibrosis* / genetics
Primary Myelofibrosis* / metabolism
Primary Myelofibrosis* / mortality
Primary Myelofibrosis* / pathology